Viewing Study NCT00079820


Ignite Creation Date: 2025-12-25 @ 4:10 AM
Ignite Modification Date: 2026-01-01 @ 9:45 AM
Study NCT ID: NCT00079820
Status: COMPLETED
Last Update Posted: 2014-01-13
First Post: 2004-03-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Adults
Sponsor: Sanofi Pasteur, a Sanofi Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module